Get the Stockscreener App
97.92
0.76%
0.74
Pre-market:
98.92
1.00
+1.02%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $97.92, with a volume of 2.56M.
It is up +0.76% in the last 24 hours and up +14.70% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$97.18
Open:
$97.43
24h Volume:
2.56M
Relative Volume:
0.61
Market Cap:
$47.61B
Revenue:
$6.13B
Net Income/Loss:
$272.21M
P/E Ratio:
177.36
EPS:
0.5521
Net Cash Flow:
$1.38B
1W Performance:
+3.03%
1M Performance:
+14.70%
6M Performance:
+27.19%
1Y Performance:
+45.15%
1-Day Range:
$96.64
$98.84
1-Week Range:
$95.35
$98.84
52-Week Range:
$65.15
$98.84
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
97.92 | 47.61B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
247.05 | 174.40B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
22.08 | 15.22B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
50.97 | 15.18B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
56.38 | 10.87B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | Goldman | Buy |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas stock trades steadily as senior housing recovery supports guidance - Ad-hoc-news.de
What's in the Offing for Ventas Stock This Earnings Season? - Yahoo Finance
Lasalle Investment Management Securities LLC Decreases Stake in Ventas, Inc. $VTR - MarketBeat
Ventas Is Maintained at Outperform by Mizuho - Moomoo
Ventas, Inc. (VTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Ventas stock trades steadily as senior housing recovery supports cash flow - Ad-hoc-news.de
Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating - marketscreener.com
Ventas stock trades on recurring income and 2025 growth - Ad-hoc-news.de
VENTAS INC : MIZUHO RAISES TARGET PRICE TO $104 FROM $98 - Bitget
Ventas, Inc. $VTR Shares Bought by KBC Group NV - MarketBeat
CI Investments Inc. Sells 494,259 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas (VTR) Expected to Release Earnings on Wednesday - MarketBeat
Precision Trading with Ventas Inc. (VTR) Risk Zones - Stock Traders Daily
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas (NYSE:VTR) Sets New 1-Year HighWhat's Next? - MarketBeat
Swiss National Bank Boosts Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Dimensional Fund Advisors LP Boosts Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas stock holds steady as senior housing recovery and Ventas Investment Management growth underpi - Ad-hoc-news.de
Ventas price soarsForecast today20-07-2026 - Economies.com
SEB Asset Management AB Takes Position in Ventas, Inc. $VTR - MarketBeat
California Public Employees Retirement System Trims Stock Position in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Purchases 55,339 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Holdings Lifted by Dorsey Wright & Associates - MarketBeat
Ventas stock stays supported by rent growth and steady guidance - Ad-hoc-news.de
Bank of New York Mellon Corp Sells 31,263 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock holds steady as senior housing recovery supports cash flows - Ad-hoc-news.de
Form 4 Ventas Inc For: 17 July By Investing.com - Investing.com Nigeria
Ventas (VTR) director Maurice Smith gets dividend-equivalent stock units - Stock Titan
Dividend-linked stock units credited to Ventas (VTR) director Sumit Roy - Stock Titan
Ventas (NYSE: VTR) director receives stock units via dividend equivalents - Stock Titan
Ventas (VTR) director receives 48.5130 dividend-equivalent share units at $95.0400 - Stock Titan
Ventas (NYSE: VTR) director Barnes awarded 71.615 dividend-equivalent units - Stock Titan
Ventas stock trades steady as healthcare REIT focuses on senior housing recovery and dividend stabil - Ad-hoc-news.de
Ventas Inc. (VTR) Q1 2026 Earnings: EPS Falls Short of Estimates Despite Positive Stock ReactionConsensus Miss Rate - dars.gov.et
Illinois Municipal Retirement Fund Sells 13,389 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock rises on steady 2026 earnings outlook - ad-hoc-news.de
Ventas (VTR) Lifts Annualized Dividend 8.3% As Earnings Growth Supports Payout - Sahm
Ventas Inc stock hits all-time high at 94.84 USD By Investing.com - Investing.com South Africa
Ventas Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Ventas Inc stock hits all-time high at 94.84 USD - Investing.com
Wells Fargo Keeps Their Buy Rating on Ventas (VTR) - The Globe and Mail
VENTAS INC : JEFFERIES RAISES TARGET PRICE TO $109 FROM $100 - Moomoo
Ventas (NYSE:VTR) Reaches New 1-Year HighStill a Buy? - MarketBeat
Ventas (VTR) Could Be a Great Choice - Yahoo Finance
Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating - marketscreener.com
Is Ventas stock outperforming the Dow? - MSN
Ventas stock reflects diversified healthcare real estate strategy - Ad-hoc-news.de
Why Welltower’s Growth Story Might Outrun Its Rich Valuation - Investing.com
Principal Financial Group Inc. Sells 63,314 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas stock reflects steady healthcare REIT positioning as senior housing demand grows - ad-hoc-news.de
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):